Search Results
Search for other papers by Anton Neschadim in
Google Scholar
PubMed
Search for other papers by Laura B Pritzker in
Google Scholar
PubMed
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Search for other papers by Kenneth P H Pritzker in
Google Scholar
PubMed
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Search for other papers by Donald R Branch in
Google Scholar
PubMed
Search for other papers by Alastair J S Summerlee in
Google Scholar
PubMed
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Armour Therapeutics Inc., Rna Diagnostics Inc., Departments of Laboratory Medicine and Pathobiology, Surgery, Pathology and Laboratory Medicine, Departments of Medicine, Laboratory Medicine and Pathobiology, Centre for Innovation, Division of Advanced Diagnostics – Infection and Immunity, Department of Biomedical Sciences, Departments of Surgery and Medical Imaging, Division of Urology, Prostate Centre, Ontario Cancer Institute, 124 Orchard View Boulevard, Toronto, Ontario, Canada
Search for other papers by John Trachtenberg in
Google Scholar
PubMed
Search for other papers by Joshua D Silvertown in
Google Scholar
PubMed
PA Ho YT Day JM Raobaikady B Kasprzyk PG Leese MP Potter BV Reed MJ Purohit A 2007 The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and
Search for other papers by Yevgeniya Kushchayeva in
Google Scholar
PubMed
Search for other papers by Kirk Jensen in
Google Scholar
PubMed
Search for other papers by Kenneth D Burman in
Google Scholar
PubMed
Search for other papers by Vasyl Vasko in
Google Scholar
PubMed
cancer cell death . Cancer Research 72 2634 – 2644 . ( doi:10.1158/0008-5472.CAN-11-3928 ). Chiu CT Wang Z Hunsberger JG Chuang DM 2013 Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Hannah Nieto in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Kristien Boelaert in
Google Scholar
PubMed
Liao L 2013 In vitro evaluation of the therapeutic potential of nevirapine in treatment of human thyroid anaplastic carcinoma . Molecular and Cellular Endocrinology 370 113 – 118 . ( doi:10.1016/j.mce.2013.02.001 ) Durante C Costante
Search for other papers by Felicity E B May in
Google Scholar
PubMed
Search for other papers by Bruce R Westley in
Google Scholar
PubMed
6 301 – 304 . ( doi:10.2217/bmm.12.22 ). May FEB 2014 Novel drugs that target the estrogen-related receptor α: their therapeutic potential in breast cancer . Cancer Management and Research 6 225 – 252 . ( doi:10.2147/CMAR
Search for other papers by Masaki Shiota in
Google Scholar
PubMed
Search for other papers by Momoe Itsumi in
Google Scholar
PubMed
Search for other papers by Ario Takeuchi in
Google Scholar
PubMed
Departments of Urology, Anatomic Pathology, Department of Urology, Department of Clinical Chemistry and Laboratory Medicine, Graduate School of Medical Sciences, Kyushu University, 3‐1‐1 Maidashi, Higashi‐ku, Fukuoka 812‐8582, Japan
Search for other papers by Kenjiro Imada in
Google Scholar
PubMed
Search for other papers by Akira Yokomizo in
Google Scholar
PubMed
Search for other papers by Hidetoshi Kuruma in
Google Scholar
PubMed
Search for other papers by Junichi Inokuchi in
Google Scholar
PubMed
Search for other papers by Katsunori Tatsugami in
Google Scholar
PubMed
Search for other papers by Takeshi Uchiumi in
Google Scholar
PubMed
Search for other papers by Yoshinao Oda in
Google Scholar
PubMed
Search for other papers by Seiji Naito in
Google Scholar
PubMed
therapeutic potential . Frontiers in Bioscience 16 865 – 897 . ( doi:10.2741/3725 ). Zeisberg M Neilson EG 2009 Biomarkers for epithelial-mesenchymal transitions . Journal of Clinical Investigation 119 1429 – 1437 . ( doi:10.1172/JCI36183
Search for other papers by Athanasios Bikas in
Google Scholar
PubMed
Search for other papers by Kirk Jensen in
Google Scholar
PubMed
Search for other papers by Aneeta Patel in
Google Scholar
PubMed
Search for other papers by John Costello Jr in
Google Scholar
PubMed
Search for other papers by Dennis McDaniel in
Google Scholar
PubMed
Search for other papers by Joanna Klubo-Gwiezdzinska in
Google Scholar
PubMed
Search for other papers by Olexander Larin in
Google Scholar
PubMed
Search for other papers by Victoria Hoperia in
Google Scholar
PubMed
Search for other papers by Kenneth D Burman in
Google Scholar
PubMed
Search for other papers by Lisa Boyle in
Google Scholar
PubMed
Search for other papers by Leonard Wartofsky in
Google Scholar
PubMed
Search for other papers by Vasyl Vasko in
Google Scholar
PubMed
– 2362 . ( doi:10.1158/1535-7163.MCT-11-0497 ). Cho SW Yi KH Han SK Sun HJ Kim YA Oh BC Park YJ Park do J 2014 Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo . Molecular and Cellular
Search for other papers by Kathrin A Schmohl in
Google Scholar
PubMed
Search for other papers by Andrea M Müller in
Google Scholar
PubMed
Search for other papers by Alexandra Wechselberger in
Google Scholar
PubMed
Department of Internal Medicine II, Medizinische Klinik und Poliklinik IV, Department of Biology II, Leibniz Institute for Environmental Medicine, Department of Nuclear Medicine, University Medical Center Hamburg‐Eppendorf, University Hospital of Munich, Munich, Germany
Search for other papers by Svenja Rühland in
Google Scholar
PubMed
Search for other papers by Nicole Salb in
Google Scholar
PubMed
Search for other papers by Nathalie Schwenk in
Google Scholar
PubMed
Search for other papers by Heike Heuer in
Google Scholar
PubMed
Search for other papers by Janette Carlsen in
Google Scholar
PubMed
Department of Internal Medicine II, Medizinische Klinik und Poliklinik IV, Department of Biology II, Leibniz Institute for Environmental Medicine, Department of Nuclear Medicine, University Medical Center Hamburg‐Eppendorf, University Hospital of Munich, Munich, Germany
Search for other papers by Burkhard Göke in
Google Scholar
PubMed
Search for other papers by Peter J Nelson in
Google Scholar
PubMed
Search for other papers by Christine Spitzweg in
Google Scholar
PubMed
after application of 131 I or 188 Re based on NIS-mediated radioiodine accumulation ( Knoop et al . 2011 , Knoop et al . 2013 ). However, full therapeutic potential can only be exploited when MSCs are efficiently recruited to their site of action
Department of Physiology and Cell Biology, Molecular, Genomic Medicine, Laboratory of Human Cancer Genetics, Center for Biostatistics, Cellular and Developmental Biology Graduate Program, The Ohio State University, 1645 Neil Avenue, 304 Hamilton Hall, Columbus, Ohio 43210, USA
Search for other papers by Aparna Lakshmanan in
Google Scholar
PubMed
Department of Physiology and Cell Biology, Molecular, Genomic Medicine, Laboratory of Human Cancer Genetics, Center for Biostatistics, Cellular and Developmental Biology Graduate Program, The Ohio State University, 1645 Neil Avenue, 304 Hamilton Hall, Columbus, Ohio 43210, USA
Search for other papers by Anna Wojcicka in
Google Scholar
PubMed
Search for other papers by Marta Kotlarek in
Google Scholar
PubMed
Search for other papers by Xiaoli Zhang in
Google Scholar
PubMed
Department of Physiology and Cell Biology, Molecular, Genomic Medicine, Laboratory of Human Cancer Genetics, Center for Biostatistics, Cellular and Developmental Biology Graduate Program, The Ohio State University, 1645 Neil Avenue, 304 Hamilton Hall, Columbus, Ohio 43210, USA
Search for other papers by Krystian Jazdzewski in
Google Scholar
PubMed
Department of Physiology and Cell Biology, Molecular, Genomic Medicine, Laboratory of Human Cancer Genetics, Center for Biostatistics, Cellular and Developmental Biology Graduate Program, The Ohio State University, 1645 Neil Avenue, 304 Hamilton Hall, Columbus, Ohio 43210, USA
Search for other papers by Sissy M Jhiang in
Google Scholar
PubMed
therapeutic potential . Cell and Tissue Research 358 1 – 15 . ( doi:10.1007/s00441-013-1787-3 ). Marsee DK Venkateswaran A Tao H Vadysirisack D Zhang Z Vandre DD Jhiang SM 2004 Inhibition of heat shock protein 90, a novel RET/PTC1
Search for other papers by Wu Guojun in
Google Scholar
PubMed
Search for other papers by Guo Wei in
Google Scholar
PubMed
Search for other papers by Ouyan Kedong in
Google Scholar
PubMed
Search for other papers by He Yi in
Google Scholar
PubMed
Search for other papers by Xie Yanfei in
Google Scholar
PubMed
Search for other papers by Chen Qingmei in
Google Scholar
PubMed
Search for other papers by Zhang Yankai in
Google Scholar
PubMed
Search for other papers by Wu Jie in
Google Scholar
PubMed
Search for other papers by Fan Hao in
Google Scholar
PubMed
Search for other papers by Li Taiming in
Google Scholar
PubMed
Search for other papers by Liu Jingjing in
Google Scholar
PubMed
Search for other papers by Cao Rongyue in
Google Scholar
PubMed
treatment of tumor by vaccines is the therapeutic potential vaccines. Therefore, a therapeutic vaccination protocol was designed as shown in Fig. 3 A. At day 0, EMT-6 breast tumor cells (2×10 5 ) were injected subcutaneously into three groups of mice. The
Search for other papers by Sumie Kato in
Google Scholar
PubMed
Search for other papers by Anil Sadarangani in
Google Scholar
PubMed
Search for other papers by Soledad Lange in
Google Scholar
PubMed
Search for other papers by Manuel Villalón in
Google Scholar
PubMed
Search for other papers by Jorge Brañes in
Google Scholar
PubMed
Search for other papers by Jan J Brosens in
Google Scholar
PubMed
Search for other papers by Gareth I Owen in
Google Scholar
PubMed
Search for other papers by Mauricio Cuello in
Google Scholar
PubMed
cells, providing further support for its therapeutic potential in reproductive tract malignancies. The mechanism by which 2ME mediates apoptosis is accompanied by an increase in the number of cells in the S or G2/M phase of the cell cycle, as